104 related articles for article (PubMed ID: 27288297)
21. Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection.
Liu X; Yu L; Han C; Lu S; Zhu G; Su H; Qin W; Liao X; Peng T
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):739-747. PubMed ID: 27288300
[TBL] [Abstract][Full Text] [Related]
22. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
[TBL] [Abstract][Full Text] [Related]
23. Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Yoo T; Lee KW; Yi NJ; Choi YR; Kim H; Suh SW; Jeong JH; Lee JM; Suh KS
J Korean Med Sci; 2016 Jul; 31(7):1049-54. PubMed ID: 27366001
[TBL] [Abstract][Full Text] [Related]
24. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
25. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
26. Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma.
Xie CR; Sun HG; Sun Y; Zhao WX; Zhang S; Wang XM; Yin ZY
Mol Med Rep; 2015 Sep; 12(3):4203-4209. PubMed ID: 26095787
[TBL] [Abstract][Full Text] [Related]
27. Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients.
Zhang H; Guo X; Dai J; Wu Y; Ge N; Yang Y; Ji J; Zhang H
Med Oncol; 2014 Nov; 31(11):278. PubMed ID: 25355558
[TBL] [Abstract][Full Text] [Related]
28. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
Han X; Xing Q; Li Y; Sun J; Ji H; Huazheng P; Jun L
Hepatogastroenterology; 2012 Oct; 59(119):2285-9. PubMed ID: 22456434
[TBL] [Abstract][Full Text] [Related]
29. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
30. Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.
Pasic I; Wong KM; Lee JJ; Espin-Garcia O; Brhane Y; Cheng D; Chen Z; Patel D; Brown C; Bucur R; Reisman D; Knox JJ; Xu W; Hung RJ; Liu G; Cleary SP
Mol Carcinog; 2018 Jan; 57(1):106-113. PubMed ID: 28892201
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in POLG were associated with the prognosis and mtDNA content in hepatocellular carcinoma patients.
Long X; Wang X; Chen Y; Guo X; Zhou F; Fan Y; Ge N; Guo M; Zhang Z; Dong G
Bull Cancer; 2017 Jun; 104(6):500-507. PubMed ID: 28457473
[TBL] [Abstract][Full Text] [Related]
32. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants in genes of tricarboxylic acid cycle key enzymes predict postsurgical overall survival of patients with hepatocellular carcinoma.
Du X; Wan S; Chen Y; Qu P; Huang X; Yu X; Yang H; Zhang Y; Xing J
Ann Surg Oncol; 2014 Dec; 21(13):4300-7. PubMed ID: 25081338
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients.
Qu K; Liu SS; Wang ZX; Huang ZC; Liu SN; Chang HL; Xu XS; Lin T; Dong YF; Liu C
World J Gastroenterol; 2015 Apr; 21(14):4310-22. PubMed ID: 25892883
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B.
Jung SW; Park NH; Shin JW; Park BR; Kim CJ; Lee JE; Shin ES; Kim JA; Chung YH
Hepatology; 2014 May; 59(5):1912-20. PubMed ID: 23907815
[TBL] [Abstract][Full Text] [Related]
36. Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection.
Fu SJ; Qi CY; Xiao WK; Li SQ; Peng BG; Liang LJ
Surgery; 2013 Sep; 154(3):536-44. PubMed ID: 23601901
[TBL] [Abstract][Full Text] [Related]
37. Single nucleotide polymorphisms of XRCC3 gene in hepatocellular carcinoma - relationship with clinicopathological features.
Avadanei ER; Giusca SE; Negura L; Caruntu ID
Pol J Pathol; 2018; 69(1):73-81. PubMed ID: 29895130
[TBL] [Abstract][Full Text] [Related]
38. Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma.
Wang JH; Wei W; Xu J; Guo ZX; Xiao CZ; Zhang YF; Jian PE; Wu XL; Shi M; Guo RP
Oncotarget; 2015 Oct; 6(33):35116-28. PubMed ID: 26375669
[TBL] [Abstract][Full Text] [Related]
39. Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma.
Ma S; Yang J; Song C; Ge Z; Zhou J; Zhang G; Hu Z
PLoS One; 2017; 12(3):e0173700. PubMed ID: 28339471
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
Chen GG; Ho RL; Wong J; Lee KF; Lai PB
Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
